Skip to main content

Want a detailed portfolio tracker?

Coya Therapeutics (COYA) Income Statement (2022 - 2026)

Income Statement report data from Mar 31, 2022 to Mar 31, 2026 for Coya Therapeutics (COYA).

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

Reported currency: USD
Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022
Revenue and COGS
Total Revenue
250K
(-93.69%)
3.96M
(+11.24%)
3.56M
(+2125.00%)
160K
(-38.46%)
260K--3.43M
(+2538.46%)
130K
(-97.83%)
6.00M-------
Operating Expenses
Research And Development
4.10M
(-17.00%)
4.94M
(+69.18%)
2.92M
(-20.22%)
3.66M
(-29.75%)
5.21M
(+168.56%)
1.94M
(-12.61%)
2.22M
(-51.42%)
4.57M
(+45.54%)
3.14M
(+95.03%)
1.61M
(+1.26%)
1.59M
(+48.60%)
1.07M
(-13.01%)
1.23M
(+73.24%)
710K
(-44.53%)
1.28M
(-11.72%)
1.45M
(+47.96%)
980K
Selling General And Administrative
3.78M
(+15.60%)
3.27M
(+27.73%)
2.56M
(-12.03%)
2.91M
(+7.38%)
2.71M
(+26.64%)
2.14M
(-3.60%)
2.22M
(+6.22%)
2.09M
(-14.34%)
2.44M
(+2.52%)
2.38M
(+21.43%)
1.96M
(+7.10%)
1.83M
(+10.24%)
1.66M
(+84.44%)
900K
(-27.42%)
1.24M
(-37.69%)
1.99M
(+176.39%)
720K
Operating Expenses
7.89M
(-21.02%)
9.99M
(+66.50%)
6.00M
(-8.81%)
6.58M
(-17.02%)
7.93M
(+94.36%)
4.08M
(-8.31%)
4.45M
(-33.18%)
6.66M
(+18.72%)
5.61M
(+33.89%)
4.19M
(+17.70%)
3.56M
(+9.54%)
3.25M
(+12.07%)
2.90M
(+45.00%)
2.00M
(-24.81%)
2.66M
(-22.90%)
3.45M
(+102.94%)
1.70M
Depreciation And Amortization
-10K
(0.00%)
10K
(0.00%)
10K
(0.00%)
10K
(0.00%)
10K
(0.00%)
10K
(0.00%)
10K
(0.00%)
10K
(0.00%)
10K
(0.00%)
10K
(0.00%)
10K
(0.00%)
10K
(0.00%)
10K
(0.00%)
10K--
Operating Income
Operating Income
-7.64M
(+26.70%)
-6.03M
(+148.15%)
-2.43M
(-62.09%)
-6.41M
(-16.54%)
-7.68M
(+88.24%)
-4.08M
(-8.31%)
-4.45M
(+37.35%)
-3.24M
(-40.88%)
-5.48M1.82M-3.56M
(+9.54%)
-3.25M
(+12.07%)
-2.90M
(+45.00%)
-2.00M
(-24.81%)
-2.66M
(-22.90%)
-3.45M
(+102.94%)
-1.70M
Ebit
-7.64M
(+26.70%)
-6.03M
(+148.15%)
-2.43M
(-62.09%)
-6.41M
(-16.54%)
-7.68M
(+88.24%)
-4.08M
(-8.31%)
-4.45M
(+37.35%)
-3.24M
(-40.88%)
-5.48M1.82M-3.56M
(+9.54%)
-3.25M
(+12.07%)
-2.90M
(+45.00%)
-2.00M
(-24.81%)
-2.66M
(-22.90%)
-3.45M
(+102.94%)
-1.70M
EBITDA
-7.64M
(+26.91%)
-6.02M
(+147.74%)
-2.43M
(-62.09%)
-6.41M
(-16.43%)
-7.67M
(+88.45%)
-4.07M
(-8.33%)
-4.44M
(+37.46%)
-3.23M
(-41.06%)
-5.48M1.82M-3.56M
(+9.54%)
-3.25M
(+12.46%)
-2.89M
(+44.50%)
-2.00M
(-24.53%)
-2.65M
(-22.97%)
-3.44M
(+102.35%)
-1.70M
Other Income / Expenses
Other Non Operating Income
430K
(-67.67%)
1.33M
(+315.63%)
320K
(0.00%)
320K
(-13.51%)
370K
(-77.58%)
1.65M
(+283.72%)
430K
(+26.47%)
340K
(-20.93%)
430K
(-32.81%)
640K
(+357.14%)
140K
(-12.50%)
160K
(0.00%)
160K
(+166.67%)
60K
(+50.00%)
40K
(+300.00%)
10K-
Net Income
Income Before Tax
-7.21M
(-7.80%)
-7.82M--6.09M
(-16.69%)
-7.31M
(-4.57%)
-7.66M--2.89M
(-42.77%)
-5.05M
(-30.44%)
-7.26M----12.24M---
Income Tax Expense
------720.00K---720K-------
Net Income From Continuing Operations
-7.21M
(+26.27%)
-5.71M
(+169.34%)
-2.12M
(-65.19%)
-6.09M
(-16.69%)
-7.31M
(+150.34%)
-2.92M
(-27.36%)
-4.02M
(+39.10%)
-2.89M
(-42.77%)
-5.05M1.27M-3.42M
(+10.32%)
-3.10M
(+13.14%)
-2.74M
(-11.90%)
-3.11M
(-22.64%)
-4.02M
(+17.89%)
-3.41M
(+100.59%)
-1.70M
Net Income
-7.21M
(+26.27%)
-5.71M
(+169.34%)
-2.12M
(-65.19%)
-6.09M
(-16.69%)
-7.31M
(+150.34%)
-2.92M
(-27.36%)
-4.02M
(+39.10%)
-2.89M
(-42.77%)
-5.05M1.27M-3.42M
(+10.32%)
-3.10M
(+13.14%)
-2.74M
(-11.90%)
-3.11M
(-22.64%)
-4.02M
(+17.89%)
-3.41M
(+100.59%)
-1.70M